What is GIR?
The Glucose Infusion Rate (GIR) is a measure of the amount of glucose being delivered to a patient per kilogram of body weight per minute, expressed in mg/kg/min. It is one of the most important calculations in neonatal and pediatric intensive care, where maintaining stable blood glucose levels is critical for brain development and overall survival. GIR allows clinicians to standardize glucose delivery across patients of different sizes and to titrate intravenous dextrose solutions to achieve target blood glucose levels.
Unlike simply knowing the infusion rate or dextrose concentration alone, GIR integrates both variables along with the patient's weight to provide a single, clinically meaningful number. This makes it easier to compare glucose delivery between patients, adjust infusions when switching between different dextrose concentrations, and communicate effectively during handoffs between clinical teams.
In practice, GIR is most commonly used in neonatal intensive care units (NICUs) for premature and low birth weight infants who are at high risk for both hypoglycemia and hyperglycemia. However, the concept is also applicable to pediatric and adult patients requiring parenteral nutrition or concentrated dextrose infusions for any reason.
Why GIR Matters in Neonatal Care
Newborns, particularly those born prematurely, have limited glycogen reserves and high metabolic demands relative to their body size. The brain of a neonate depends almost exclusively on glucose for energy, and even brief periods of hypoglycemia can cause irreversible neurological damage. At the same time, hyperglycemia — which is common in extremely preterm infants — is associated with increased risk of infection, intraventricular hemorrhage, and retinopathy of prematurity.
GIR provides a standardized way to ensure that glucose delivery matches the infant's metabolic needs. By calculating and monitoring GIR, clinicians can detect when glucose delivery is too low (risking hypoglycemia) or too high (risking hyperglycemia) and make timely adjustments. This is especially important in the first 24 to 72 hours of life, when blood glucose levels can fluctuate significantly as the infant transitions from placental to independent glucose regulation.
Multiple glucose sources are common in the NICU setting. An infant may be receiving maintenance fluids with one dextrose concentration, medications diluted in another concentration, and parenteral nutrition with yet another formulation. The GIR calculation sums the glucose contribution from all sources to give the total rate of glucose delivery, ensuring that nothing is overlooked when assessing the infant's glucose status.
GIR Formula Explained
The GIR formula converts the dextrose concentration and infusion rate into milligrams of glucose delivered per kilogram of body weight per minute. The calculation is performed for each infusion source individually, then the results are summed.
Glucose (mg/min) = (Dextrose% ÷ 100) × Rate (mL/hr) × 1000 ÷ 60
Total Glucose (mg/min) = Sum of all sources
GIR (mg/kg/min) = Total Glucose (mg/min) ÷ Weight (kg)
The factor of 1000 converts grams to milligrams (since dextrose concentration is in grams per mL when expressed as a percentage — for example, D10 means 10 grams of dextrose per 100 mL, or 0.1 g/mL). The factor of 60 converts the hourly rate to a per-minute rate. By dividing by the patient's weight in kilograms, we obtain a weight-normalized rate that can be compared across patients of different sizes.
Normal GIR Ranges
| Population | GIR Range (mg/kg/min) | Notes |
|---|---|---|
| Term neonate (maintenance) | 4 – 6 | Standard starting rate for most healthy term newborns |
| Preterm neonate | 4 – 8 | May need higher rates due to limited glycogen stores |
| Neonatal hypoglycemia treatment | 6 – 8 | Increased to achieve normoglycemia |
| Refractory hypoglycemia | 8 – 12 | May require central access for higher concentrations |
| Maximum (peripheral IV) | ≤ 12.5 | Limited by maximum D12.5 concentration peripherally |
| Maximum (central line) | Up to 15–20 | Higher concentrations (D20–D50) via central access |
Neonatal Hypoglycemia Management
Neonatal hypoglycemia is one of the most common metabolic problems in newborns, affecting up to 15% of all neonates and a higher proportion of those in the NICU. The definition of neonatal hypoglycemia varies somewhat between guidelines, but most institutions use a threshold of 40–47 mg/dL (2.2–2.6 mmol/L) for intervention in the first 48 hours of life, with higher thresholds for infants with risk factors.
When oral feeding is insufficient to maintain blood glucose levels, intravenous dextrose is initiated. The typical approach begins with a D10 (10% dextrose) bolus of 2 mL/kg administered over one minute (delivering 200 mg/kg of glucose), followed by a continuous infusion at a GIR of 4–6 mg/kg/min. Blood glucose is monitored every 30 to 60 minutes initially, and the GIR is titrated upward in increments of 1–2 mg/kg/min if hypoglycemia persists.
If a GIR exceeding 12 mg/kg/min is required to maintain normoglycemia, this is considered abnormal and suggests an underlying condition such as hyperinsulinism, inborn error of metabolism, or cortisol deficiency. These infants require further evaluation and may need pharmacological intervention with agents such as diazoxide, octreotide, or glucocorticoids in addition to glucose infusion.
When to Increase or Decrease GIR
The decision to adjust GIR depends on the patient's blood glucose readings and clinical status. Key scenarios include:
- Increase GIR when blood glucose remains below target despite current infusion, when transitioning off parenteral nutrition and the infant is not yet feeding adequately, or when the infant's metabolic demands increase (e.g., during sepsis, hypothermia treatment, or increased respiratory effort).
- Decrease GIR when blood glucose rises above the target range (generally above 150–180 mg/dL in neonates), when the infant is establishing oral feeds and absorbing glucose enterally, or when stepping down from treatment for hypoglycemia as the underlying condition resolves.
- Wean gradually: GIR should generally be decreased in increments of 1–2 mg/kg/min every 4–6 hours, with blood glucose monitoring before and after each change. Abrupt discontinuation of high-rate glucose infusions can cause rebound hypoglycemia.
Central vs. Peripheral Lines
The maximum dextrose concentration that can safely be infused through a peripheral intravenous line is typically 12.5% (D12.5). Higher concentrations are hyperosmolar and can cause phlebitis, tissue damage, and extravasation injury if they infiltrate into surrounding tissues. For a 3 kg infant receiving D12.5 at a reasonable fluid rate, the maximum achievable GIR through a peripheral IV is approximately 10–12 mg/kg/min.
When higher GIR is needed, central venous access is required. A centrally placed catheter (umbilical venous catheter, peripherally inserted central catheter, or surgically placed central line) can safely deliver concentrations up to D20, D25, or even higher in some situations. Central access also allows for the administration of total parenteral nutrition (TPN), which typically contains dextrose concentrations of 10–25% along with amino acids, lipids, vitamins, and minerals.
The choice between increasing concentration and increasing infusion rate depends on the clinical context. In fluid-restricted patients (e.g., those with congestive heart failure, renal failure, or cerebral edema), increasing dextrose concentration is preferred over increasing volume. In patients who can tolerate additional fluid, increasing the infusion rate with a lower concentration may be simpler and safer.
Frequently Asked Questions
What is a normal GIR for a newborn?
A typical maintenance GIR for a healthy term newborn is 4–6 mg/kg/min. This is usually achieved with D10 at standard maintenance fluid rates (approximately 60–80 mL/kg/day on day one of life, increasing to 100–150 mL/kg/day by day three). Preterm infants or those with specific metabolic needs may require higher rates.
How do I calculate GIR when an infant receives TPN?
TPN solutions contain a specific dextrose concentration (often listed on the label or calculated from the order). Treat the TPN as one of your dextrose sources: enter its concentration and infusion rate into the calculator along with any other glucose-containing fluids the infant is receiving. The total GIR from all sources will be calculated automatically.
Why is GIR important even when blood glucose is normal?
Monitoring GIR even when blood glucose is normal helps anticipate problems. For example, if an infant is maintaining normal glucose on a GIR of 12 mg/kg/min, this abnormally high requirement suggests an underlying condition even though the current glucose level is satisfactory. Conversely, if GIR is being weaned, tracking the rate helps ensure smooth transitions without rebound hypoglycemia.
Can GIR be used for adult patients?
Yes, although it is less commonly calculated explicitly in adult medicine. The same formula applies: total glucose infused per minute divided by body weight. In adult ICU settings, glucose delivery is often managed through TPN protocols and insulin infusions, but the underlying concept is the same. Adult endogenous glucose production is approximately 2–3 mg/kg/min, which is lower than in neonates (4–6 mg/kg/min).
What does D10 mean?
D10 refers to a 10% dextrose solution, meaning there are 10 grams of dextrose (glucose) per 100 mL of solution. Similarly, D5 contains 5 grams per 100 mL, D12.5 contains 12.5 grams per 100 mL, and so on. The "D" stands for dextrose, which is the pharmaceutical term for glucose used in intravenous solutions.
How do I convert between different dextrose concentrations?
To deliver the same GIR with a different dextrose concentration, adjust the infusion rate proportionally. For example, if switching from D10 at 80 mL/hr to D5, you would need to double the rate to 160 mL/hr to maintain the same glucose delivery. In practice, this calculation should always be confirmed with the GIR formula to avoid errors.